---
layout: minimal-medicine
title: Antihemophilic Factor VIII (Recombinant) Pegylated
---

# Antihemophilic Factor VIII (Recombinant) Pegylated
### Generic Name
Antihemophilic Factor VIII (Recombinant) Pegylated

### Usage
Antihemophilic factor VIII (recombinant) pegylated is primarily used to treat and prevent bleeding episodes in individuals with hemophilia A.  Hemophilia A is a genetic disorder where the blood doesn't clot properly due to a deficiency or absence of factor VIII, a crucial clotting protein. This medication acts as a replacement for the missing or deficient factor VIII, allowing the blood to clot effectively and stop bleeding.  It's used for both routine prophylaxis (preventative treatment) to reduce the frequency and severity of bleeds, and for on-demand treatment of bleeding episodes as they occur.  The medication can be used in various bleeding situations, from minor cuts to major surgical procedures.

### Dosage

Dosage is highly individualized and depends on several factors, including the patient's weight, the severity of the bleeding, and the desired increase in factor VIII activity.  The following is general guidance only, and **a healthcare professional must determine the appropriate dose for each individual.**  Dosage is typically expressed in International Units (IU) per kilogram (kg) of body weight.

**Adults:**

* **Hemorrhage (Bleeding Episodes):** The dose varies significantly depending on the severity of the bleeding (minor, moderate, or major).  Generally, a dose is calculated based on body weight and the desired increase in factor VIII levels in the blood. The specific dosage range and frequency of administration (every 8-24 hours)  will be determined by a doctor, considering the severity of the bleed.

* **Perioperative Prophylaxis (Before and After Surgery):** Doses range from 30-60 IU/kg depending on the type of surgery (minor or major) and are administered intravenously (IV) before surgery.  Further doses may be needed post-surgery until adequate wound healing is observed.

* **Prophylaxis (Preventative Treatment):**  A typical prophylactic dose is 40-50 IU/kg administered intravenously twice a week. The specific dosage and frequency might be adjusted based on individual response.

**Children:**

Dosage calculations for children follow a similar principle to adults, but the dose and frequency may vary based on age and weight.  Always consult with a pediatrician or hematologist for specific dosage instructions for children.  The guidelines for hemorrhage treatment and perioperative prophylaxis are generally similar to adults, with adjustments in frequency depending on age. Prophylactic dosing in children is often higher than in adults.

**Important Note:** One IU/kg of this medication increases plasma factor VIII by approximately 2 IU/dL of plasma.

**Administration:** This medication is administered intravenously (IV) via injection.  The injection speed should not exceed 10 mL/min.

### Side Effects

**Common Side Effects:** Headache is a commonly reported side effect.  Nausea may occur.

**Less Common but Serious Side Effects:**  Development of neutralizing antibodies (inhibitors) to factor VIII is a serious risk.  Hypersensitivity reactions, including anaphylaxis (a severe allergic reaction), are possible.


**Important:**  If you experience any adverse effects, especially those listed as serious, immediately contact a healthcare provider.

### How it Works

Antihemophilic factor VIII (recombinant) pegylated is a genetically engineered form of factor VIII. It works by replacing the missing or deficient factor VIII protein in individuals with hemophilia A. Factor VIII is essential for blood clotting.  This medication helps to form a stable blood clot, thereby stopping or preventing bleeding episodes.  The pegylation process increases the medication's half-life in the body, meaning that it stays active for a longer duration.

### Precautions

* **Contraindications:**  This medication is contraindicated (should not be used) in individuals with a history of anaphylactic reactions to the medication itself, the parent molecule (recombinant factor VIII), or any of its components (like mouse or hamster protein, Tris, mannitol, trehalose, glutathione, or polysorbate 80).


* **Hypersensitivity Reactions:**  There's an increased risk of hypersensitivity reactions, including anaphylaxis.  Close monitoring is necessary, and appropriate emergency measures must be available.


* **Inhibitor Development:** Some patients develop antibodies (inhibitors) that neutralize the effects of factor VIII.  Regular monitoring is important to detect these inhibitors.


* **Pregnancy and Lactation:**  The safety of this medication during pregnancy and lactation is not fully established.  Consult a healthcare professional before using this medication if you are pregnant, breastfeeding, or planning to become pregnant.


* **Renal and Hepatic Impairment:** Currently, there are no specific dosage adjustments recommended by the manufacturer for patients with renal or hepatic impairment.


* **Other Medications:**  Although no specific significant interactions are listed, inform your doctor of all medications you are taking, including over-the-counter drugs and supplements.


### FAQs

* **Q: How long does it take for this medication to work?**  A: The effect of the medication begins relatively quickly after intravenous administration, but the duration depends on the dose and the individual's response.

* **Q: How should I store this medication?** A: Store the medication (both the lyophilized powder and diluent) in a refrigerator. Once reconstituted, the solution should be administered promptly and discarded after 3 hours.

* **Q: What should I do if I miss a dose?** A: Consult your doctor immediately to determine the appropriate course of action.  Missed doses could increase the risk of bleeding.

* **Q: Are there any long-term effects associated with this medication?** A: While generally safe, long-term use requires careful monitoring for inhibitor development and other potential adverse effects.  Regular check-ups with your doctor are important.

* **Q: Can I use this medication if I have allergies?** A: If you have a history of allergies, especially to components of this medication, inform your doctor before using it.  This medication is contraindicated in those with a history of anaphylaxis to it or its components.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a qualified healthcare professional for diagnosis, treatment, and management of any medical condition.  The information provided here is not exhaustive and may not cover all possible side effects, precautions, or interactions.  Always refer to the medication's official prescribing information for the most accurate and up-to-date details.
